me 2303 has been researched along with nadp in 1 studies
Studies (me 2303) | Trials (me 2303) | Recent Studies (post-2010) (me 2303) | Studies (nadp) | Trials (nadp) | Recent Studies (post-2010) (nadp) |
---|---|---|---|---|---|
23 | 1 | 0 | 21,608 | 25 | 3,484 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kim, WB; Lee, MG; Lee, SD; Lee, WI; Shim, HJ; Yang, J; Yoon, EJ | 1 |
1 other study(ies) available for me 2303 and nadp
Article | Year |
---|---|
Comparison of pharmacokinetics of M1, M2, M3, and M4 after intravenous administration of DA-125 or ME2303 to mice and rats. New adriamycin analogues containing fluorine.
Topics: Animals; Anti-Infective Agents; Bile; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Doxorubicin; Gastric Mucosa; Hydrogen-Ion Concentration; In Vitro Techniques; Injections, Intravenous; Intestine, Small; Kidney; Liver; Lung; Male; Mice; Mice, Inbred ICR; Myocardium; NADP; Rabbits; Rats; Rats, Sprague-Dawley; Rats, Wistar; Species Specificity; Tissue Distribution | 1996 |